GLN-DAPAGLIFLOZIN
Identification of Gln-Dapagliflozin
| No description |
Google image searchProduct monograph
Active ingredient
dapagliflozin, 5 MG
DIN: 02519852
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 23-MAY-2023
ATC:
- A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
- A10B — BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS (ATC, ATC/DDD)
- A10BK — Sodium-glucose co-transporter 2 (SGLT2) inhibitors (ATC, ATC/DDD)
- A10BK01 — DAPAGLIFLOZIN (ATC/DDD)
Reference brand drug: Forxiga
